Filing Details
- Accession Number:
- 0001209191-22-049352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-09 18:00:23
- Reporting Period:
- 2022-09-07
- Accepted Time:
- 2022-09-09 18:00:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1659323 | Iterum Therapeutics Plc | ITRM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1553593 | W. Michael Dunne | C/O Iterum Therapeutics Plc Fitzwilliam Court, Fl. 1, Leeson Close Dublin 2 L2 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-09-07 | 10,000 | $2.22 | 35,576 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported on this Form 4 have been adjusted to reflect the Reverse Share Split.
Billionaire Hedge Funds
